Archives

by in
Entry Author Date Location
The Innovation Challenge: Assessing BioPharma Startups 05/04/15 Seattle
A New Day for Digital DNA 04/14/15 Boston
Six Takeaways From “New York’s Life Science Disruptors” 03/16/15 New York
Resistance Is Futile: Why That’s A Good Thing In Biomedicine 02/09/15 Seattle
Exosome Dx, Aiming to Commercialize “Liquid Biopsies,” Seeks $25M 01/28/15 Boston
Biotech Startups Tap Spider Genes in Quest to Spin Silk Gold 10/14/14 Raleigh Durham
With FDA Nod, T2 Bio’s Sepsis Test Heads to Commercial Proving Ground 09/23/14 Boston
Hear Epizyme, Sage, Zafgen Share Their Stories on Oct. 8 09/11/14 Boston
Military Strategies Being Used in the War on Cancer 08/04/14 Seattle
San Diego’s Synthorx Adds To Genetic Alphabet, Aims for Bio-Products 05/07/14 San Diego
FDA Panel Gives Exact’s Colon Cancer Test Ringing Endorsement 03/27/14 Wisconsin
Exact Sciences’ Colon Cancer Test Clears Key Hurdle, FDA Next 03/19/14 Wisconsin
Lucigen Takes On Diagnostic Giants With On-the-Spot Pathogen Tests 01/30/14 Wisconsin
Madison Vaccines Closes $8M Series A Round for Prostate Treatment 01/13/14 Wisconsin
Milwaukee Water Tech Startups: 3 Themes to Watch 01/13/14 Wisconsin
Microbe Detectives Brings DNA Sequencing to Water 01/02/14 Wisconsin
Genia Aims to Build the iPhone of Gene Sequencing 10/16/13 San Francisco
San Diego Life Sciences Roundup: Arena, Organovo, Isis, & More 06/13/13 San Diego
The Right Reasons to Be Transparent 06/13/13 San Francisco
The Intersection of the Double Helix and Life Sciences in Seattle 01/22/13 Seattle
San Diego Life Sciences Roundup: Halozyme, Sophiris, Arena, & More 07/12/12 San Diego
Rubicon Genomics Launches New DNA Amplification Technology 06/05/12 Detroit
UCSD Spinoff NexDx Aims to Diagnose Rheumatoid Arthritis 04/11/12 San Diego
24-Hour, Full-Genome Scans 12/23/11 San Francisco
NABsys Takes in $10M Round, Led by Stata, for Gene Sequencing Tools 09/15/11 Boston
T2 Biosystems Closes $23M More for Fast, Cheap Diagnostic Tools 08/10/11 Boston
Metamark, Stealthy Startup with Dana-Farber Roots, Seeks to Tell Docs When to Treat Prostate Cancer, and When Not 02/24/11 Boston
RainDance Raises $37.5M 01/25/11 Boston
QuantaLife Closes $17M Round 12/13/10 San Francisco
Compendia Bioscience Morphs Into Big Pharma’s Cancer Genomics Partner 10/21/10 Detroit
Page 1 of 2 next page »